Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 111 | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 548.05 USD | +1.44% | +8.77% | +14.33% | +38.57% | 138.91 B USD | ||
| 197 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 834.04 USD | +0.90% | +4.03% | +25.93% | +41.11% | 85.87 B USD | ||
| 263 | ARGX argenx SE - American Depositary Shares | 1039.78 USD | +0.16% | +12.13% | +13.64% | +51.67% | 64.35 B USD | ||
| 288 | MRNA Moderna, Inc. - Common Stock | 145.13 USD | +8.86% | +125.88% | +164.64% | +435.14% | 57.94 B USD | ||
| 352 | RVMD Revolution Medicines, Inc. - Common Stock | 209.46 USD | -1.08% | +2.67% | +10.88% | +278.09% | 44.89 B USD | ||
| 445 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 236.22 USD | +3.02% | +4.63% | -13.94% | -47.90% | 31.61 B USD | ||
| 477 | BNTX BioNTech SE - American Depositary Shares | 116.57 USD | +5.12% | +25.05% | +30.27% | +5.14% | 27.97 B USD | ||
| 484 | INSM Insmed Incorporated - Common Stock | 125.77 USD | +0.55% | +0.85% | +17.51% | -22.39% | 27.47 B USD | ||
| 488 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.31 USD | +1.21% | +5.05% | +4.22% | +64.55% | 27.38 B USD | ||
| 505 | ROIV Roivant Sciences Ltd. - Common Shares | 36.30 USD | -1.47% | +0.22% | +3.21% | +98.25% | 26.22 B USD | ||
| 508 | INCY Incyte Corporation - Common Stock | 127.81 USD | +0.46% | +6.37% | +8.62% | +50.36% | 25.91 B USD | ||
| 575 | UTHR United Therapeutics Corporation - Common Stock | 513.12 USD | -1.51% | +2.22% | -3.13% | +65.14% | 22.01 B USD | ||
| 676 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 254.28 USD | +2.24% | +3.83% | -0.20% | +81.63% | 16.51 B USD | ||
| 687 | BBIO BridgeBio Pharma, Inc. - Common Stock | 81.50 USD | -1.74% | +2.97% | -3.02% | +42.98% | 15.93 B USD | ||
| 696 | ASND Ascendis Pharma A/S - American Depositary Shares | 253.29 USD | -0.60% | +2.80% | -0.89% | +23.51% | 15.70 B USD | ||
| 773 | EXEL Exelixis, Inc. - Common Stock | 54.08 USD | +0.73% | +5.52% | -3.10% | +38.52% | 13.40 B USD | ||
| 779 | CORT Corcept Therapeutics Incorporated - Common Stock | 122.25 USD | +0.99% | +6.30% | +33.46% | +66.62% | 13.22 B USD | ||
| 794 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 66.70 USD | -1.45% | -0.45% | +11.37% | +13.28% | 12.91 B USD | ||
| 818 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 87.11 USD | -0.41% | +0.78% | +1.30% | +122.79% | 12.30 B USD | ||
| 821 | HALO Halozyme Therapeutics, Inc. - Common Stock | 108.17 USD | +1.93% | +9.42% | +31.26% | +61.93% | 12.28 B USD |
Noticias Biotechnology Stocks
La FDA amplía la revisión de Deramiocel de Capricor hasta el 22 de noviembre
GRI Bio presentará datos de su fármaco para FPI en el Congreso ERS
Alnylam presentará datos clínicos sobre ATTR e hipertensión en el ESC
Lexicon recibe un hito de 10 millones de dólares de Novo Nordisk por fármaco contra la obesidad
FibroBiologics nombra a Leigh Steinberg miembro de su consejo
La FDA confirma reunión sobre el catéter Helix de BioCardia
Humacyte planea presentar ante la FDA en noviembre su solicitud para diálisis
Gainers Biotechnology Stocks
LIMN Liminatus Pharma, Inc. - Class A Common Stock | 5.15 | +4581.82% |
SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 3.22 | +1010.34% |
ELAB PMGC Holdings Inc. - Common Stock | 6.66 | +991.80% |
HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.87 | +102.33% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.55 | +38.39% |
NTRBW Nutriband Inc. - Warrant | 0.5000 | +25.06% |
ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 13.45 | +22.38% |
Losers Biotechnology Stocks
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0010 | -52.38% |
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
XCUR Exicure, Inc. - Common Stock | 1.15 | -11.54% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.39 | -11.36% |
CURX Curanex Pharmaceuticals Inc - Common Stock | 4.71 | -10.63% |
HURA TuHURA Biosciences, Inc. - Common Stock | 2.00 | -9.91% |